Cargando…

Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity

Hyperglycemia in diabetes mellitus induces modification of proteins by glucose and its derivative methylglyoxal (MG). Neutrophils perform their bactericidal activity mainly via reactive halogen (RHS) and oxygen (ROS) species generation catalyzed by myeloperoxidase (MPO) stored in neutrophil azurophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Panasenko, Oleg M., Ivanov, Viktor A., Mikhalchik, Elena V., Gorudko, Irina V., Grigorieva, Daria V., Basyreva, Liliya Yu., Shmeleva, Ekaterina V., Gusev, Sergey A., Kostevich, Valeria A., Gorbunov, Nikolay P., Sokolov, Alexey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686918/
https://www.ncbi.nlm.nih.gov/pubmed/36421449
http://dx.doi.org/10.3390/antiox11112263
_version_ 1784835873940963328
author Panasenko, Oleg M.
Ivanov, Viktor A.
Mikhalchik, Elena V.
Gorudko, Irina V.
Grigorieva, Daria V.
Basyreva, Liliya Yu.
Shmeleva, Ekaterina V.
Gusev, Sergey A.
Kostevich, Valeria A.
Gorbunov, Nikolay P.
Sokolov, Alexey V.
author_facet Panasenko, Oleg M.
Ivanov, Viktor A.
Mikhalchik, Elena V.
Gorudko, Irina V.
Grigorieva, Daria V.
Basyreva, Liliya Yu.
Shmeleva, Ekaterina V.
Gusev, Sergey A.
Kostevich, Valeria A.
Gorbunov, Nikolay P.
Sokolov, Alexey V.
author_sort Panasenko, Oleg M.
collection PubMed
description Hyperglycemia in diabetes mellitus induces modification of proteins by glucose and its derivative methylglyoxal (MG). Neutrophils perform their bactericidal activity mainly via reactive halogen (RHS) and oxygen (ROS) species generation catalyzed by myeloperoxidase (MPO) stored in neutrophil azurophilic granules (AGs) and membrane NADPH oxidase, respectively. Herein, we study the binding of human serum albumin (HSA) modified with MG (HSA-MG) to MPO and its effects on MPO activity and release by neutrophils. Peroxidase activity of MPO was registered by oxidation of 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, and chlorinating activity by decolorization of Celestine blue B dye. Binding of HSA-MG to MPO was studied by affinity chromatography, disc-electrophoresis, ligand Western blotting and enzyme-linked solid phase immunoassay using monoclonal antibodies (mAbs) to MPO. ROS and RHS generation were detected by lucigenin (Luc) and luminol (Lum) chemiluminescence (CL), respectively. Neutrophil degranulation was assessed by flow cytometry using fluorescent labeled antibodies to the marker proteins CD63 from AGs and CD11b from peroxidase-negative granules (PNGs). NETosis was assayed by quantifying DNA network-like structures (NET-like structures) in blood smears stained by Romanowsky. HSA-MG bound to MPO, giving a stable complex (K(d) = 1.5 nM) and competing with mAbs, and non-competitively inhibited peroxidase and chlorinating MPO activity and induced degranulation of PNGs but not of AGs. HSA-MG enhanced Luc-CL per se or following PMA, unlike Lum-CL, and did not affect spontaneous or PMA-stimulated NETosis. Thus, HSA modified under hyperglycemia-like conditions stimulated NADPH oxidase of neutrophils but dampened their functions dependent on activity of MPO, with no effect on its release via degranulation or NETosis. This phenomenon could underlie the downregulation of bactericidal activity of MPO and neutrophils, and hence of innate immunity, giving rise to wound healing impairment and susceptibility to infection in patients with hyperglycemia.
format Online
Article
Text
id pubmed-9686918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96869182022-11-25 Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity Panasenko, Oleg M. Ivanov, Viktor A. Mikhalchik, Elena V. Gorudko, Irina V. Grigorieva, Daria V. Basyreva, Liliya Yu. Shmeleva, Ekaterina V. Gusev, Sergey A. Kostevich, Valeria A. Gorbunov, Nikolay P. Sokolov, Alexey V. Antioxidants (Basel) Article Hyperglycemia in diabetes mellitus induces modification of proteins by glucose and its derivative methylglyoxal (MG). Neutrophils perform their bactericidal activity mainly via reactive halogen (RHS) and oxygen (ROS) species generation catalyzed by myeloperoxidase (MPO) stored in neutrophil azurophilic granules (AGs) and membrane NADPH oxidase, respectively. Herein, we study the binding of human serum albumin (HSA) modified with MG (HSA-MG) to MPO and its effects on MPO activity and release by neutrophils. Peroxidase activity of MPO was registered by oxidation of 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, and chlorinating activity by decolorization of Celestine blue B dye. Binding of HSA-MG to MPO was studied by affinity chromatography, disc-electrophoresis, ligand Western blotting and enzyme-linked solid phase immunoassay using monoclonal antibodies (mAbs) to MPO. ROS and RHS generation were detected by lucigenin (Luc) and luminol (Lum) chemiluminescence (CL), respectively. Neutrophil degranulation was assessed by flow cytometry using fluorescent labeled antibodies to the marker proteins CD63 from AGs and CD11b from peroxidase-negative granules (PNGs). NETosis was assayed by quantifying DNA network-like structures (NET-like structures) in blood smears stained by Romanowsky. HSA-MG bound to MPO, giving a stable complex (K(d) = 1.5 nM) and competing with mAbs, and non-competitively inhibited peroxidase and chlorinating MPO activity and induced degranulation of PNGs but not of AGs. HSA-MG enhanced Luc-CL per se or following PMA, unlike Lum-CL, and did not affect spontaneous or PMA-stimulated NETosis. Thus, HSA modified under hyperglycemia-like conditions stimulated NADPH oxidase of neutrophils but dampened their functions dependent on activity of MPO, with no effect on its release via degranulation or NETosis. This phenomenon could underlie the downregulation of bactericidal activity of MPO and neutrophils, and hence of innate immunity, giving rise to wound healing impairment and susceptibility to infection in patients with hyperglycemia. MDPI 2022-11-16 /pmc/articles/PMC9686918/ /pubmed/36421449 http://dx.doi.org/10.3390/antiox11112263 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Panasenko, Oleg M.
Ivanov, Viktor A.
Mikhalchik, Elena V.
Gorudko, Irina V.
Grigorieva, Daria V.
Basyreva, Liliya Yu.
Shmeleva, Ekaterina V.
Gusev, Sergey A.
Kostevich, Valeria A.
Gorbunov, Nikolay P.
Sokolov, Alexey V.
Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity
title Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity
title_full Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity
title_fullStr Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity
title_full_unstemmed Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity
title_short Methylglyoxal-Modified Human Serum Albumin Binds to Leukocyte Myeloperoxidase and Inhibits its Enzymatic Activity
title_sort methylglyoxal-modified human serum albumin binds to leukocyte myeloperoxidase and inhibits its enzymatic activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686918/
https://www.ncbi.nlm.nih.gov/pubmed/36421449
http://dx.doi.org/10.3390/antiox11112263
work_keys_str_mv AT panasenkoolegm methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT ivanovviktora methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT mikhalchikelenav methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT gorudkoirinav methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT grigorievadariav methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT basyrevaliliyayu methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT shmelevaekaterinav methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT gusevsergeya methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT kostevichvaleriaa methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT gorbunovnikolayp methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity
AT sokolovalexeyv methylglyoxalmodifiedhumanserumalbuminbindstoleukocytemyeloperoxidaseandinhibitsitsenzymaticactivity